Skip to content
10-K/A

Annual Report

Terns Pharmaceuticals, Inc.

0001193125-26-182140

← back to feed
Filed
Apr 27, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 17, 2026 115.52M sh